Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-08-20
Original SEC Filing: Click here

---

Webplus: SVA/20180820/6-K/2_EX-99.1/000.htm SEC Original: tv501368_ex99-1.htm
SEC Concludes Investigation of Sinovac About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical Company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases. Sinovac’s product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps. Healive, the

---

---

Webplus: SVA/20180820/6-K/1/000.htm SEC Original: tv501368_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2018-08-20CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200